310 related articles for article (PubMed ID: 18540841)
1. Current data on ATP-containing liposomes and potential prospects to enhance cellular energy status for hepatic applications.
Korb V; Tep K; Escriou V; Richard C; Scherman D; Cynober L; Chaumeil J; Dumortier G
Crit Rev Ther Drug Carrier Syst; 2008; 25(4):305-45. PubMed ID: 18540841
[TBL] [Abstract][Full Text] [Related]
2. Formulation and evaluation of ATP-containing liposomes including lactosylated ASGPr ligand.
Tep K; Korb V; Richard C; Escriou V; Largeau C; Vincourt V; Bessodes M; Guellier A; Scherman D; Cynober L; Chaumeil JC; Dumortier G
J Liposome Res; 2009; 19(4):287-300. PubMed ID: 19863164
[TBL] [Abstract][Full Text] [Related]
3. Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver.
Fumoto S; Nakadori F; Kawakami S; Nishikawa M; Yamashita F; Hashida M
Pharm Res; 2003 Sep; 20(9):1452-9. PubMed ID: 14567641
[TBL] [Abstract][Full Text] [Related]
4. Cold preservation injury in rat liver: effect of liposomally-entrapped adenosine triphosphate.
Neveux N; De Bandt JP; Fattal E; Hannoun L; Poupon R; Chaumeil JC; Delattre J; Cynober LA
J Hepatol; 2000 Jul; 33(1):68-75. PubMed ID: 10905588
[TBL] [Abstract][Full Text] [Related]
5. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
Managit C; Kawakami S; Yamashita F; Hashida M
J Pharm Sci; 2005 Oct; 94(10):2266-75. PubMed ID: 16136555
[TBL] [Abstract][Full Text] [Related]
6. Effect of apoE/ATP-containing liposomes on hepatic energy state.
Chaïb S; Charrueau C; Neveux N; Nakib S; Chaumeil JC; Cynober L; De Bandt JP
Liver Int; 2003 Oct; 23(5):379-85. PubMed ID: 14708900
[TBL] [Abstract][Full Text] [Related]
7. Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition.
Murao A; Nishikawa M; Managit C; Wong J; Kawakami S; Yamashita F; Hashida M
Pharm Res; 2002 Dec; 19(12):1808-14. PubMed ID: 12523658
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice.
Ishida E; Managit C; Kawakami S; Nishikawa M; Yamashita F; Hashida M
Pharm Res; 2004 Jun; 21(6):932-9. PubMed ID: 15212156
[TBL] [Abstract][Full Text] [Related]
9. Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo.
Rensen PC; Sliedregt LA; Ferns M; Kieviet E; van Rossenberg SM; van Leeuwen SH; van Berkel TJ; Biessen EA
J Biol Chem; 2001 Oct; 276(40):37577-84. PubMed ID: 11479285
[TBL] [Abstract][Full Text] [Related]
10. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
Liu X; Han M; Xu J; Geng S; Zhang Y; Ye X; Gou J; Yin T; He H; Tang X
Int J Pharm; 2017 Mar; 520(1-2):98-110. PubMed ID: 28167263
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery.
Pathak PO; Nagarsenker MS; Barhate CR; Padhye SG; Dhawan VV; Bhattacharyya D; Viswanathan CL; Steiniger F; Fahr A
Carbohydr Res; 2015 May; 408():33-43. PubMed ID: 25841057
[TBL] [Abstract][Full Text] [Related]
12. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
Kawakami S; Yamashita F; Nishikawa M; Takakura Y; Hashida M
Biochem Biophys Res Commun; 1998 Nov; 252(1):78-83. PubMed ID: 9813149
[TBL] [Abstract][Full Text] [Related]
13. Hepatic preservation, liposomally entrapped adenosine triphosphate and nitric oxide production: a study of energy state and protein metabolism in the cold-stored rat liver.
Neveux N; De Bandt JP; Chaumeil JC; Cynober L
Scand J Gastroenterol; 2002 Sep; 37(9):1057-63. PubMed ID: 12374232
[TBL] [Abstract][Full Text] [Related]
14. Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs.
Kawakami S; Munakata C; Fumoto S; Yamashita F; Hashida M
J Pharm Sci; 2001 Feb; 90(2):105-13. PubMed ID: 11169527
[TBL] [Abstract][Full Text] [Related]
15. In vivo gene delivery to the liver using novel galactosylated cationic liposomes.
Kawakami S; Fumoto S; Nishikawa M; Yamashita F; Hashida M
Pharm Res; 2000 Mar; 17(3):306-13. PubMed ID: 10801219
[TBL] [Abstract][Full Text] [Related]
16. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
[TBL] [Abstract][Full Text] [Related]
17. Effect of hydrophile-lipophile balance of the linker in Gal/GalNAc ligands on high-affinity binding of galactosylated liposomes by the asialoglycoprotein receptor.
Nie H; Liu XM; Yang QX; Luo XD; Zhao Y; Zhang SY
Int J Pharm; 2022 Aug; 624():121967. PubMed ID: 35777585
[TBL] [Abstract][Full Text] [Related]
18. Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.
D'Souza AA; Devarajan PV
J Control Release; 2015 Apr; 203():126-39. PubMed ID: 25701309
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte-targeting gene delivery using a lipoplex composed of galactose-modified aromatic lipid synthesized with click chemistry.
Sakashita M; Mochizuki S; Sakurai K
Bioorg Med Chem; 2014 Oct; 22(19):5212-9. PubMed ID: 25155912
[TBL] [Abstract][Full Text] [Related]
20. Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in vivo evaluation.
Pathak P; Dhawan V; Magarkar A; Danne R; Govindarajan S; Ghosh S; Steiniger F; Chaudhari P; Gopal V; Bunker A; Róg T; Fahr A; Nagarsenker M
Int J Pharm; 2016 Jul; 509(1-2):149-158. PubMed ID: 27231122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
